NPHS1, NPHS1 adhesion molecule, nephrin, 4868

N. diseases: 87; N. variants: 189
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0036690
Disease: Septicemia
Septicemia
0.010 Biomarker disease BEFREE These two DNA probes should greatly facilitate epidemiological studies to assess the importance of CNF-producing strains as agents of diarrhoea and septicaemia. 8006936 1994
Diabetes Mellitus, Non-Insulin-Dependent
0.020 AlteredExpression disease BEFREE Metformin treatment of T2DM rats produced dose-dependent significant reductions in urinary albumin and nephrin concentrations, glomerular basement membrane thickness (GBMT), and the foot process fusion rate (FPFR) compared with control T2DM model rats, whereas renal expression of nephrin protein and Nphs1 mRNA was dose-dependently increased by metformin treatment. 27248136 2017
CUI: C0042029
Disease: Urinary tract infection
Urinary tract infection
0.020 Biomarker group BEFREE While further examination of CNF-1 may reveal a role in UTI pathogenesis, our data casts doubt on the role of CNF-1 in the pathogenesis of UPEC UTI. 28545489 2017
Focal Segmental Glomerulosclerosis, Not Otherwise Specified
0.020 GeneticVariation disease BEFREE We present a 12-year-old girl with rapidly progressive FSGS and end-stage renal disease in her native kidneys associated with heterozygous mutations in NPHS1 and in NPHS2, suffering from early post-transplant recurrence. 27312921 2016
CUI: C0027720
Disease: Nephrosis
Nephrosis
0.020 Biomarker disease BEFREE Loss of function for crb2b and nphs1 in Danio rerio were previously shown to result in loss of the slit diaphragms of the podocytes, leading to the hypothesis that nephrosis develops from an inability to develop a functional glomerular barrier. 25557780 2015
CUI: C0265962
Disease: Ichthyosis linearis circumflexa
Ichthyosis linearis circumflexa
0.020 GeneticVariation disease BEFREE Mutation analysis was carried out by direct sequencing of the NPHS1 and NPHS2 genes in 145 nephrotic syndrome (NS) patients. 22565185 2012
CUI: C1112705
Disease: Nuclear non-senile cataract
Nuclear non-senile cataract
0.020 GeneticVariation disease BEFREE Mutation analysis was carried out by direct sequencing of the NPHS1 and NPHS2 genes in 145 nephrotic syndrome (NS) patients. 22565185 2012
CUI: C0011847
Disease: Diabetes
Diabetes
0.020 GeneticVariation disease BEFREE The single nucleotide polymorphism rs#466452 of the nephrin gene seems to be neutral in relation to diabetes and the development of diabetic nephropathy, and does not affect the splicing of a nephrin transcript, in spite of a splicing enhancer site. 19746264 2009
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.020 GeneticVariation group BEFREE The single nucleotide polymorphism rs#466452 of the nephrin gene seems to be neutral in relation to diabetes and the development of diabetic nephropathy, and does not affect the splicing of a nephrin transcript, in spite of a splicing enhancer site. 19746264 2009
CUI: C0011847
Disease: Diabetes
Diabetes
0.020 GeneticVariation disease BEFREE We amplified and sequenced a 514 bp promoter region of 100 individuals and found no genetic variants in the purine-rich GAGA-box of the nephrin gene promoter between groups of patients with diabetes type 2 with and without renal and coronary complications, control patients without diabetes and healthy controls. 18449463 2007
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.020 GeneticVariation group BEFREE We amplified and sequenced a 514 bp promoter region of 100 individuals and found no genetic variants in the purine-rich GAGA-box of the nephrin gene promoter between groups of patients with diabetes type 2 with and without renal and coronary complications, control patients without diabetes and healthy controls. 18449463 2007
Diabetes Mellitus, Non-Insulin-Dependent
0.020 GeneticVariation disease BEFREE We amplified and sequenced a 514 bp promoter region of 100 individuals and found no genetic variants in the purine-rich GAGA-box of the nephrin gene promoter between groups of patients with diabetes type 2 with and without renal and coronary complications, control patients without diabetes and healthy controls. 18449463 2007
CUI: C0265962
Disease: Ichthyosis linearis circumflexa
Ichthyosis linearis circumflexa
0.020 Biomarker disease BEFREE Mutational analyses of NPHS1 and NPHS2 were performed to verify this hypothesis in sporadic nephrotic syndrome (NS) patients. 17211152 2007
CUI: C1112705
Disease: Nuclear non-senile cataract
Nuclear non-senile cataract
0.020 Biomarker disease BEFREE Mutational analyses of NPHS1 and NPHS2 were performed to verify this hypothesis in sporadic nephrotic syndrome (NS) patients. 17211152 2007
Focal Segmental Glomerulosclerosis, Not Otherwise Specified
0.020 Biomarker disease BEFREE To better study its progression, a transgenic mouse model was developed by expressing murine alpha-actinin-4 containing a mutation analogous to that affecting a human FSGS family in a podocyte-specific manner using the murine nephrin promoter. 12707390 2003
CUI: C0027720
Disease: Nephrosis
Nephrosis
0.020 Biomarker disease BEFREE Congenital nephrotic syndrome of the Finnish type (NPHS1) is an autosomal-recessive disorder, characterized by massive proteinuria in utero and nephrosis at birth. 9660941 1998
CUI: C0042029
Disease: Urinary tract infection
Urinary tract infection
0.020 GeneticVariation group BEFREE Strains from prostatitis patients were significantly more likely to express hemolysin than were strains causing complicated UTI (73% vs. 43%; P = .02) and more often demonstrated hybridization with the cytotoxic necrotizing factor-1 (CNF-1) probe (63%) than did strains from women (44%-48%). 9237713 1997
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.040 GeneticVariation disease BEFREE We present a 12-year-old girl with rapidly progressive FSGS and end-stage renal disease in her native kidneys associated with heterozygous mutations in NPHS1 and in NPHS2, suffering from early post-transplant recurrence. 27312921 2016
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.040 Biomarker disease BEFREE Genotyping for TRPC6, ACTN4, CD2AP, WT1, INF2, NPHS2 and NPHS1 was performed in all patients with primary FSGS and ESRD registered on the waiting list for kidney transplantation of a large German transplant center (n = 26 out of 478 registered patients). 22732337 2012
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.040 GeneticVariation disease BEFREE Mutations of NPHS1, NPHS2, or WT1 may be responsible for severe forms of nephrotic syndrome in children, progressing to end-stage renal failure. 15503167 2004
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.040 GeneticVariation disease BEFREE Mutations of NPHS1 or NPHS2, the genes encoding for nephrin and podocin, lead to early onset of heavy proteinuria, and rapid progression to end-stage renal disease, suggesting that both proteins are essential for the integrity of the glomerular filter. 14570703 2003
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.050 GeneticVariation disease BEFREE The single nucleotide polymorphism rs#466452 of the nephrin gene seems to be neutral in relation to diabetes and the development of diabetic nephropathy, and does not affect the splicing of a nephrin transcript, in spite of a splicing enhancer site. 19746264 2009
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.050 GeneticVariation disease BEFREE In this work, using bioinformatic tools, we identified a purine-rich GAGA element in the nephrin gene promoter and conducted a genomic study in search of the presence of polymorphisms in this element and its possible association with DN in type 2 diabetic patients. 18449463 2007
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.050 AlteredExpression disease LHGDN Expression of human nephrin mRNA in diabetic nephropathy. 14736962 2004
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.050 Biomarker disease LHGDN This study does not support an involvement of the coding region of the nephrin gene in the pathogenesis of diabetic nephropathy in type 1 diabetic patients. 12631336 2003